Preliminary studies were conducted at Chulalongkorn University in Bangkok, Thailand, one of a few labs in Asia used by the US Centers of Disease Control (CDC) to conduct research on treatments of H5N1.
Patricia Gruden, CEO of eFoodSafety, said: “These findings are considered to be a breakthrough in the field of treatment against bird flu, and we believe that our results mark a critical development in the global initiative to eradicate the disease. This is yet another example of how eFoodSafety is committed to improving health conditions affecting people across the world.”